United States Department of Agriculture National

New Post Public Reply Private Reply Replies (0) Message Board
john1234 mc67 #44
332
United States Department of Agriculture

National Institute of Food and Agriculture

Industrial Hemp

As a result of Section 7606 of the Agricultural Act of 2014 (“Farm Bill”) regarding industrial hemp, the U.S. Department of Agriculture (USDA) in consult with the U.S. Drug Enforcement Administration (DEA) and the U.S. Food and Drug Administration (FDA), recently published a notice in the Federal Register (August 12, 2016; 81 FR 53395).

This document(link is external) is a “Statement of Principles” to inform the public how federal law applies to activities associated with industrial hemp that is grown and cultivated in accordance with Section 7606.

The term “industrial hemp” includes the plant Cannabis sativa L. and any part or derivative of such plant, including seeds of such plant, whether growing or not, that is used exclusively for industrial purposes (fiber and seed) with a tetrahydrocannabinols concentration of not more than 0.3 percent on a dry weight basis. The term “tetrahydrocannabinols” includes all isomers, acids, salts, and salts of isomers of tetrahydrocannabinols.

The Statement of Principles informs individuals, institutions, and states how to legally participate in industrial hemp research, in states where such activity is legal, if they wish to do so. As reflected in this guidance, eligible National Institute of Food and Agriculture (NIFA) program participants may be able to use agency funding for industrial hemp research in some circumstances that are consistent with existing program priorities.

Consistent with the Statement of Principles, NIFA will, at a minimum, be taking the following steps:
•Include a related certification as part of the submission of applications to NIFA for federal financial assistance. This will be implemented with applications submitted on or after Oct. 1, 2016.
•Include an award term and condition. The award term will be included with new awards or those receiving a funding increment on or after Oct. 1, 2016.
•Make available a frequently asked questions (FAQs) document.

NIFA is authorized to support industrial hemp research where such activity complies with state law. Further, the researcher must either:
•Be an institution of higher education or state department of agriculture as defined by 20 U.S.C. 1001 (see https://www.gpo.gov/fdsys/pkg/USCODE-2011-tit...1.htm(link is external)) or
•Grow the industrial hemp under the auspices of a state agricultural pilot program.

This web page will be updated with additional information as appropriate. For media inquiries contact sally.gifford@nifa.usda.gov(link sends e-mail), for all other inquires contact whoffman@nifa.usda.gov(link sends e-mail).

Frequently Asked Questions

Question 1: Will agricultural research pilot programs that conduct experiments involving growing industrial hemp still require DEA permitting?

Answer: No, as long as the hemp in question is grown or cultivated under a license, registration, authorization, or production lease with a state pilot program under (or otherwise compliant with) Section 7606. DEA permitting is required under the Controlled Substances Act (CSA). The 2014 Farm Bill legitimized industrial hemp research “notwithstanding” the CSA, if performed pursuant to section 7606. Therefore, industrial hemp legitimately may be grown or cultivated either pursuant to section 7606 or in connection with a DEA permit.

Question 2: What do I need to do if I want to legally conduct an experiment that involves growing industrial hemp?

Answer: First, the experiment must be conducted in a state that has legalized the production of hemp. Second, the researcher must either (a) be an institution of higher education or state department of agriculture or (b) grow the industrial hemp under the auspices of a state agricultural pilot program.

Question 3: If I apply for a USDA funded research grant for such an industrial hemp experiment, will USDA be permitted to fund my proposal?

Answer: Yes, provided the criteria (in question 2), above are met. Depending on the funding agency, applicants likely will need to certify compliance with the relevant State program and agree to certain terms and conditions as set by the agency.

Question 4: Can universities who receive capacity funding from NIFA utilize these dollars to support industrial hemp research?

Answer: Yes. Entities eligible to receive capacity funding from NIFA would not lose their eligibility merely because their research involves growing or cultivating industrial hemp, as long as that research is conducted under a license, registration, authorization, or production lease with a state pilot program under Section 7606 or otherwise represents legal activity within the state. Universities who receive these capacity funds may choose to devote a portion of them to industrial hemp research, consistent with other statutes and regulations governing those funds.

Question 5: How can I find out what types of industrial hemp activities are legal in my state?

Answer: Consult your organization’s legal counsel and the state agency responsible for the hemp pilot research program in your state. While organizations like the National Conference of State Legislatures(link is external) maintain websites that summarize State Industrial Hemp Statutes across the country, these websites should not be used to provide advice or assistance to private citizens or organizations regarding industrial hemp laws or other related matters.

Question 6: May producers grow hemp under this program for production of food and pharmaceutical products?

Answer: Section 7606 does not affect the requirements that already exist for the production of food and pharmaceutical products under the Federal Food, Drug, and Cosmetic Act or the Controlled Substances Act. For example, section 7606 did not alter the approval process for new drug applications or any other authorities of the FDA, nor does it alter the requirements of the Controlled Substances Act that apply to the manufacture, distribution, and dispensing of drug products containing controlled substances. Whether hemp may be grown for food and pharmaceutical products remains a question for the FDA and/or the DEA.

Question 7: Is DEA permitting still required for seed importation?

Answer: Section 7606 specifically authorized certain entities to “grow or cultivate” industrial hemp but did not eliminate the requirement under the Controlled Substances Import and Export Act that the importation of viable cannabis seeds must be carried out by persons registered with the DEA to do so. In addition, any USDA phytosanitary requirements that normally would apply to the importation of plant material will apply to the importation of industrial hemp seed.

Question 8: Is it possible for NIFA to support projects focused on post-harvest uses of industrial hemp?

Answer: Yes. In legitimizing industrial hemp research, section 7606 did not make any distinction between pre-harvest and post-harvest industrial hemp. Moreover, the law defines “industrial hemp” to include the plant Cannabis sativa L. “and any part or derivative of such plant ... whether growing or not, that is used exclusively for industrial purposes (fiber and seed) with a tetrahydrocannabinols concentration of not more than 0.3 percent on a dry weight basis.” This definition, therefore, covers post-harvest stalks, as well as the fibers and other derivatives of the plant.

source
https://nifa.usda.gov/industrial-hemp

here is the section of the 2014 farm bill referenced above
http://www.kyagr.com/marketing/documents/HEMP...4.7606.pdf
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 258

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading

Top 5 Most Recently Viewed Articles

Omni-Lite Industries Reports Impressive Fiscal Q3 Results

Updated Category News Views 143

Highlights from Omni-Lite's Third Quarter Fiscal 2025 Outstanding Financial Performance Omni-Lite Industries Canada Inc. (TSXV: OML) recently reported its financial results for the third quarter of fiscal 2025, demonstrating notable growth and resilience. With revenue reaching approximately US$4.0 million, Omni-Lite saw a remarkable year-over-year increase of 7.0%...

Continue Reading
Assessing the Impact of UK Fiscal Policy on Housing Market Trends

Updated Category News Views 200

Understanding the Current UK Housing Market Dynamics The U.K. housing market is currently facing a notable slowdown, primarily driven by tax-related uncertainties associated with fiscal policies. As potential buyers adopt a more cautious stance, residential property transactions have seen a decline. This trend poses immediate risks for sectors linked to housing, including...

Continue Reading
Radford Racing School Unveils New Exciting Driving Adventures

Updated Category News Views 226

Exciting New Driving Experiences at Radford Racing School Recently, Radford Racing School, known as a leader in performance driving education, announced its latest offerings that promise to thrill automotive enthusiasts of all ages and skill levels. With the introduction of six new driving experiences, there's now something for everyone at their legendary racetrack....

Continue Reading
AppLovin CEO Sells $21.5 Million in Shares Amid Growth Momentum

Updated Category News Views 137

AppLovin CEO's Notable Stock Sale Recently, AppLovin Corp (NASDAQ: APP) made headlines with a significant financial event: CEO and Chairperson Arash Adam Foroughi sold over $21.5 million worth of company stock. According to the latest SEC filing, this noteworthy transaction occurred over just two days, with share prices varying from $98.08 to $112.33 during that time....

Continue Reading
Olverembatinib's Breakthrough Status Enhances Leukemia Treatment Options

Updated Category News Views 396

Olverembatinib Gains Breakthrough Therapy Designation Ascentage Pharma, a prominent global biopharmaceutical company, is making significant strides in the treatment of serious medical conditions. With its latest achievement, olverembatinib has secured a Breakthrough Therapy Designation in China for its use alongside low-intensity chemotherapy in newly-diagnosed patients...

Continue Reading